Overview Tenecteplase Pulmonary Embolism Italian Study Status: Terminated Trial end date: 2006-07-01 Target enrollment: Participant gender: Summary To assess the efficacy and safety of Tenecteplase versus Placebo in normotensive patients with sub-massive Pulmonary Embolism and Right Ventricular Dysfunction (RVD) all receiving unfractionated heparin (UFH) Phase: Phase 2 Details Lead Sponsor: University Of PerugiaTreatments: TenecteplaseTissue Plasminogen Activator